Barinthus Biotherapeutics Plc Adr (BRNS)

Jul 16, 2025

BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com

Jul 16, 2025

Apr 01, 2025

BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com

Apr 01, 2025

Jan 31, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq

Jan 31, 2025

Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025

Dec 04, 2024

The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice

Dec 04, 2024

Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024

Sep 03, 2024

Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research

Sep 03, 2024

Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK

Jun 21, 2024

Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024

Nov 21, 2017

Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat

Nov 21, 2017